Abstral-Sublingual Tablets

Abstral Sublingual Tablets: Rapid Relief for Breakthrough Cancer Pain

Abstral Sublingual Tablets represent a breakthrough in pain management technology, offering cancer patients fast-acting relief when they need it most. These innovative sublingual tablets are specifically designed for opioid-tolerant adults experiencing breakthrough cancer pain.

Fast-Acting Technology

Abstral utilizes advanced sublingual delivery that dissolves rapidly under the tongue, bypassing the digestive system for:

• Quick onset – Pain relief begins within minutes

• Predictable absorption – Consistent medication delivery

• Convenient administration – No water needed, discrete usage

Precise Dosing Options

Available in multiple strengths (100mcg, 200mcg, 300mcg, 400mcg, 600mcg, 800mcg) to allow healthcare providers to:

• Customize treatment to individual patient needs

• Titrate effectively for optimal pain control

• Minimize side effects through proper dosing

Patient-Focused Benefits

• Rapid relief when breakthrough pain strikes

• Proven efficacy in clinical studies

• Quality of life improvement through better pain management

• Trusted solution prescribed by pain specialists worldwide

Important Safety Information

Abstral contains fentanyl, a potent opioid medication requiring careful management:

• For opioid-tolerant patients only

• Must be prescribed by certified healthcare providers

• Requires patient education on proper usage

• Regular monitoring essential for safe continued use

Why Healthcare Providers Choose Abstral

• Proven track record in breakthrough cancer pain management

• Flexible dosing options for personalized care

• Rapid action when patients need relief most

• Comprehensive support programs available